Skip to page content

This page gives you information about care following your ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.

Sedation

The medications used for sedation can remain in the body for at least 24 hours, gradually wearing off.

Information:

It is therefore very important that a capable adult is available to take you home and stay with you for the next 24 hours.

It is also important that for the next 24 hours you follow the advice below:

  • You should not drive or ride a bicycle as your reflexes and judgement will be impaired.
  • Sedation can make you unsteady on your feet. Please be careful on stairs and have someone with you if you feel unsteady.
  • Your judgement may be affected so do not make any important decisions or sign any legal documents.
  • Be careful using social media.
  • You should not return to work, look after dependants, cook or operate machinery.
  • You should not drink any alcohol or take sleeping tablets.

When can you eat and drink?

Your healthcare provider will advise when you can eat and drink from.

You can eat and drink normally after discharge from the time indicated above, although we do recommend a lighter diet for today.

Medication

You can take your usual prescribed medications when they are next due unless otherwise stated by the Endoscopist or discharging nurse. For blood thinning medications (anticoagulants) separate advice will be given.

After effects

You may experience the following:

  • A bloated, windy feeling – moving around may help to relieve this.
  • A sore throat for a short time after the procedure. This is normal and should pass within 2 days.

Following an ERCP, there is a small risk of:

  • Inflammation of the pancreas, this is called pancreatitis. It can be painful and usually requires admission to hospital for treatment.

What happens next?

  • A report will be sent to your GP.
  • If a consultant follow up is needed you will receive an appointment letter in the post.

A member of the nursing team will have explained to you what has been done today and any further tests that you may need.

When to seek advice

Serious side effects are rare after ERCP. However, attend or call the Surgical Assessment unit (SAU) if any of the following occur:

  • Severe pain in the abdomen, chest or neck.
  • Severe sickness or vomiting.
  • Vomiting blood or bowel motion turns black.
  • High temperature (fever) or you feel generally unwell.
  • Disorientation (feeling lost or confused).

You have been given Buscopan® to relax your stomach during the procedure. Please seek urgent medical advice if you experience any of the following:

  • Painful red eye with loss of vision.
  • Blurred, misty or foggy vision.
  • Nausea and/or vomiting.
  • Unable to pass urine.

Contact information

  • If you have any concerns, please contact one of the following for advice:Surgical Assessment Unit
  • ERCP Advice Line (answer machine)
  • Endoscopy Unit where you were seen
  • Your GP

Surgical Assessment Unit (SAU. Ward 5B in Tower Block)

Tel: 03004 225616

Open 24h. You can come at any time.

ERCP Advice Line (answer machine)

Tel: 0300 422 2314

Monday to Friday, 8:00am to 6:00pm

Endoscopy Unit Gloucestershire Royal Hospital

Tel: 0300 422 8222

Monday to Friday, 8:00am to 6:00pm

Out of hours, please contact NHS 111 for advice: Tel: 111

Information:

If you think you require immediate medical attention, please phone 999 or go to your nearest Accident & Emergency Department.

Feedback

To help the Endoscopy Department understand what is important to you and how we can improve our service, we would appreciate if you would take the time to complete a feedback survey.

All responses will be anonymous and any information provided will be used sensitively and stored securely.

To access the survey, please type in this ‘case sensitive’ link into your internet browser.

https://bit.ly/3MHOXIG

Printable version of this page

Discharge advice following an ERCP procedure GHPI1517_02_26 Department: Colorectal Review due: February 2029 PDF, 508.2 KB, 8 pages
Reference number GHPI1517_02_26
Department Colorectal
Review due February 2029